5540eur
2,2 %
Date:2025-05-15Time:11:56:06Latest report:Q1-2025List:Large CapTicker:ORNAV
Market Cap:7 805 meurEnterprise Value:7 867 meurNet Sales:1 589 meurEarnings:347,4 meurEmployees:0ISIN:FI0009014369

Ratios

10-year key figure history for Orion A turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Orion A with index and moving average MA50 and MA200.

Stockprice:55,40
MA50:53,34
MA200:48,33
Price/MA200:14,4 %
RSI (14):57,1
Price/MA50:3,7 %

Description

Orion operates in the pharmaceutical industry. The company conducts research and development of human and veterinary drugs, where the main focus is on diseases that affect the nervous system, as well as oncology and respiratory diseases. Today, the company's products are found on a global level, with the largest presence in the Nordic region and the rest of Europe. The company's head office is located in Espoo, Finland.

Pharmaceuticals